Kathleen A. White

ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA.

ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA.